Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001741830-25-000024
Filing Date
2025-05-08
Accepted
2025-05-08 16:21:04
Documents
72
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kron-20250331.htm   iXBRL 10-Q 697547
2 EX-31.1 kron10-q3312025exhibit311.htm EX-31.1 20491
3 EX-32.1 kron10-q3312025exhibit321.htm EX-32.1 7136
  Complete submission text file 0001741830-25-000024.txt   4993056

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kron-20250331.xsd EX-101.SCH 37713
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT kron-20250331_cal.xml EX-101.CAL 59419
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT kron-20250331_def.xml EX-101.DEF 174289
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kron-20250331_lab.xml EX-101.LAB 532471
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kron-20250331_pre.xml EX-101.PRE 368739
74 EXTRACTED XBRL INSTANCE DOCUMENT kron-20250331_htm.xml XML 574180
Mailing Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402
Business Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402 (650) 781-5200
Kronos Bio, Inc. (Filer) CIK: 0001741830 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39592 | Film No.: 25926547
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)